288 related articles for article (PubMed ID: 24175178)
1. Platelets: A possible glance into brain biological processes in schizophrenia.
Asor E; Ben-Shachar D
World J Psychiatry; 2012 Dec; 2(6):124-33. PubMed ID: 24175178
[TBL] [Abstract][Full Text] [Related]
2. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acid supplementation for schizophrenia.
Joy CB; Mumby-Croft R; Joy LA
Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
[TBL] [Abstract][Full Text] [Related]
5. [Oxidative stress involvement in schizophrenia pathophysiology: a review].
Fendri C; Mechri A; Khiari G; Othman A; Kerkeni A; Gaha L
Encephale; 2006; 32(2 Pt 1):244-52. PubMed ID: 16910626
[TBL] [Abstract][Full Text] [Related]
6. Polyunsaturated fatty acid (fish or evening primrose oil) for schizophrenia.
Joy CB; Mumby-Croft R; Joy LA
Cochrane Database Syst Rev; 2000; (2):CD001257. PubMed ID: 10796622
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets.
Ľupták M; Michaličková D; Fišar Z; Kitzlerová E; Hroudová J
World J Psychiatry; 2021 Jul; 11(7):277-296. PubMed ID: 34327122
[TBL] [Abstract][Full Text] [Related]
8. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.
Fenton WS; Hibbeln J; Knable M
Biol Psychiatry; 2000 Jan; 47(1):8-21. PubMed ID: 10650444
[TBL] [Abstract][Full Text] [Related]
9. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
du Bois TM; Deng C; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):878-88. PubMed ID: 16005134
[TBL] [Abstract][Full Text] [Related]
10. [Blood platelets: neuronal model in psychiatric disorders].
Dreux C; Launay JM
Encephale; 1985; 11(2):57-64. PubMed ID: 2862006
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types.
Dacquino C; De Rossi P; Spalletta G
Clin Chim Acta; 2015 Sep; 449():49-59. PubMed ID: 25704299
[TBL] [Abstract][Full Text] [Related]
12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
13. Animal models of schizophrenia.
Young JW; Zhou X; Geyer MA
Curr Top Behav Neurosci; 2010; 4():391-433. PubMed ID: 21312408
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.
Schwarz E; Bahn S
Expert Rev Mol Diagn; 2008 Mar; 8(2):209-16. PubMed ID: 18366307
[TBL] [Abstract][Full Text] [Related]
15. More than one century of schizophrenia: an evolving perspective.
Silveira C; Marques-Teixeira J; de Bastos-Leite AJ
J Nerv Ment Dis; 2012 Dec; 200(12):1054-7. PubMed ID: 23197119
[TBL] [Abstract][Full Text] [Related]
16. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
17. The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia.
Ohara K
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):469-74. PubMed ID: 17184889
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acids, prostaglandins, and schizophrenia.
van Kammen DP; Yao JK; Goetz K
Ann N Y Acad Sci; 1989; 559():411-23. PubMed ID: 2672945
[TBL] [Abstract][Full Text] [Related]
19. [Time perception and schizophrenia: Phenomenological and neuropsychological approach].
de Montalembert M; Tordjman S; Bonnot O; Coulon N
Encephale; 2015 Sep; 41(4 Suppl 1):S56-61. PubMed ID: 26746324
[TBL] [Abstract][Full Text] [Related]
20. Does the dopamine hypothesis explain schizophrenia?
Lau CI; Wang HC; Hsu JL; Liu ME
Rev Neurosci; 2013; 24(4):389-400. PubMed ID: 23843581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
